Clinical Trial

A Phase 2 Clinical Trial Evaluating the Efficacy and Safety of HSK21542 in Patients for Postoperative Pain Treatment in Orthopedic Surgery

Completed Phase 2
View on ClinicalTrials.gov →
Summary
This is a multi-center, randomized, double-blind, placebo/active-controlled study. 160 subjects undergoing orthopedic surgery under general anesthesia are planned to be enrolled and randomized into the HSK21542 group, morphine group, and placebo group.
Trial Details
NCT Number NCT07442877
Lead Sponsor Haisco Pharmaceutical Group Co., Ltd.
Conditions Postoperative Pain Management
Enrollment 161 participants
Start Date 2024-09-13
Primary Completion 2025-01-24 (estimated)
Study Completion 2025-01-24 (estimated)
Updated on ClinicalTrials.gov 2026-03-02